Cargando…
Adrenocortical carcinoma: presentation and outcome of a contemporary patient series
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare endocrine carcinoma with poor 5-year survival rates of < 40%. According to the literature, ACC is rarely an incidental imaging finding. However, presentation, treatment and outcome may differ in modern series. DESIGN AND METHODS: We studied all...
Autores principales: | Kostiainen, Iiro, Hakaste, Liisa, Kejo, Pekka, Parviainen, Helka, Laine, Tiina, Löyttyniemi, Eliisa, Pennanen, Mirkka, Arola, Johanna, Haglund, Caj, Heiskanen, Ilkka, Schalin-Jäntti, Camilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606857/ https://www.ncbi.nlm.nih.gov/pubmed/30980285 http://dx.doi.org/10.1007/s12020-019-01918-9 |
Ejemplares similares
-
IDH1 Expression via the R132H Mutation–Specific Antibody in Adrenocortical Neoplasias—Prognostic Impact in Carcinomas
por: Pennanen, Mirkka, et al.
Publicado: (2020) -
(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015) -
Somatostatin receptor expression in parathyroid neoplasms
por: Storvall, Sara, et al.
Publicado: (2019) -
MGMT Promoter Methylation and Parathyroid Carcinoma
por: Storvall, Sara, et al.
Publicado: (2019) -
Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
por: Vesterinen, Tiina, et al.
Publicado: (2021)